Five of 11 echinacea products fall short in examination by online testing firm, with lower-than-claimed amounts of compounds such as echinacosides and phenols the most common failing. Consumerlab gave a thumbs up to echinacea supplements marketed under the Nature's Resource, Nutrilite, Puritan's Pride, Sundown and Vitamin World brands. President Tod Cooperman, MD, says negative results may arise because "the wrong plant species or plant part may be used; levels of important plant chemicals may be low if the herb is not properly grown, harvested, processed, shipped and stored; and lead levels may be high due to contaminated soil"...
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
A new pilot aims to take Brazil closer to ‘digital transformation.’
Sarepta's rAAVrh74 vector, used in the marketed Duchenne muscular dystrophy gene therapy Elevidys and across the company's limb girdle muscular dystrophy pipeline, earned a platform designation as the lead LGMD candidate prepares for BLA filing.
Pink Sheet reporter and editors discuss the potential impact of the Most-Favored Nation drug pricing proposal on Europe, the United States, as well as the pharmaceutical industry.
Recent and upcoming US FDA advisory committee meetings and a summary of the topics covered.
